[Germ-line mutations of the BRCA1 gene in northeastern France].

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Bulletin du Cancer

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 11084537
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BRCA1, BRCA2 and their possible function in DNA damage response

  1999cited by this paper
• Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions.

  1999cited by this paper
• Frequency of BRCA1 mutation 5382insC in German breast cancer patients.

  1999cited by this paper
• Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc Committee.

  1998cited by this paper
• Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.

  1998cited by this paper
• Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.

  1998cited by this paper
• BRCA1 mutations in southern England.

  1998cited by this paper
• Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden.

  1998cited by this paper
• Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

  1998cited by this paper
• The Cancer-predisposing Mutation C61G Disrupts Homodimer Formation in the NH2-terminal BRCA1 RING Finger Domain*

  1998cited by this paper
• Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.

  1998cited by this paper
• BRCA1 and BRCA2 in breast cancer families from Wales: moderate mutation frequency and two recurrent mutations in BRCA1.

  1998cited by this paper
• Low frequency of lymph-node metastasis in BRCA1-associated breast cancer.

  1998cited by this paper
• Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.

  1997cited by this paper
• [Germ-line mutation of BRCA1 in patients with breast and/or ovarian cancer in high risk families in Northern France].

  1997cited by this paper
• A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families.

  1997cited by this paper
• BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group.

  1997cited by this paper
• BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

  1997cited by this paper
• Population genetics of BRCA1 and BRCA2.

  1997cited by this paper
• Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden.

  1996cited by this paper
• Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.

  1996cited by this paper
• A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes

  1996cited by this paper
• Growth retardation and tumour inhibition by BRCA1

  1996cited by this paper
• Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer

  1996cited by this paper
• Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer.

  1996cited by this paper
• Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations.

  1996cited by this paper
• Segregation of two BRCA1 mutations in a single family.

  1996cited by this paper
• Mutations and Polymorphisms in the familial early‐onset breast cancer (BRCA1) gene

  1996cited by this paper
• Antisense RNA to the putative tumor suppressor gene BRCA1 transforms mouse fibroblasts.

  1996cited by this paper
• Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation

  1995cited by this paper
• The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

  1995cited by this paper
• A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening.

  1995cited by this paper
• An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium.

  1995cited by this paper
• Rapid detection of BRCA1 mutations by the protein truncation test

  1995cited by this paper
• Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1995cited by this paper
• Identification of the breast cancer susceptibility gene BRCA2

  1995cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families

  1994cited by this paper
• Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

  1994cited by this paper
• Familial breast-ovarian cancer locus on chromosome 17q12-q23.

  1991cited by this paper
• Isolation of DNA from blood.

  1991cited by this paper
• Linkage of early-onset familial breast cancer to chromosome 17q21.

  1990cited by this paper

• Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria

  2018cites this paper
• Clinical and pathologic characteristics of breast cancer patients carrying the c.3481_3491del11 mutation

  2018cites this paper
• Is there a genetic anticipation in breast and/or ovarian cancer families with the germline c.3481_3491del11 mutation?

  2017cites this paper
• BRCA1 testing in breast and/or ovarian cancer families from northeastern France identifies two common mutations with a founder effect

  2004cites this paper
• Effects of filtration on glyceraldehyde-3-phosphate dehydrogenase mRNA in the plasma of trauma patients and healthy individuals.

  2004cites this paper
• Multiplex single-nucleotide primer extension analysis to simultaneously detect eleven BRCA1 mutations in breast cancer families.

  2004cites this paper
• A mutation analysis of the BRCA1 gene in 140 families from southeast France with a history of breast and/or ovarian cancer

  2003cites this paper
• Diagnostic génétique du cancer du sein et de l’ovaire héréditaire*

  2003cites this paper